Inova Schar has joined colleagues around the country and soon, around the world, as part of the COVID-19 and Cancer Consortium (CCC19), a group of over 100 cancer centers and other organizations who have come together to collect data with the common cause of understanding better the unique effects of COVID-19 on patients with cancer, including a history of cancer. The intent of the CCC19 is to rapidly collect and disseminate information about this especially vulnerable population.
Inova Loudoun Hospital scores an ‘A’ for 25 consecutive grading periods Fairfax, VA, May 1,…
According to the U.S. Centers for Disease Control and Prevention, nearly 50% of adults in…
Heather Perez Saiz, MA, LCSW, CCTSW, is the Independent Living Donor Advocate at Inova Fairfax…
Palak Shah, MD, MS Fairfax, VA — A research team at Inova Schar Heart and…
Jason Bonomo, MD, PhD, is a cardiologist at Inova Schar Heart and Vascular. Dr. Bonomo…
Update as of April 24, 2024: Inova’s structural heart team has now completed the first…